In-vitro fertilization is the process of artificial fertilization used to treat infertility or genetic problems globally. It is the most efficient assisted reproductive technology (ART), helping couples or single parents around the world. However, in-vitro fertilization does not always give successful results and its success rate varies from individual to individual. It has emerged as a preferable choice for fertility treatments in the clinical industry.
The market growth is attributed to the reduced conceiving rates, mainly in women aged 40 years or above, ovulation disorder, premature ovarian failure, uterine fibroids, damaged or blocked fallopian tube, endometriosis, impaired sperm production or function and unexplained infertility. A burgeoning medical tourism in several emerging economies, such India, Brazil, and China has fortified the demand for in-vitro fertilization treatments. Fresh Non-donor is the highest revenue-generating segment, and is expected to maintain this trend with a high growth rate throughout the analysis period. Geographically, the APAC region is estimated to dominate the global In-vitro Fertilization market during the forecasted period, majorly due to high demand for in-vitro fertilization treatments, attributed to the rising infertility in women and men in several countries. Few of the prominent players in the market are Coopersurgical Inc., Cook Medical Inc., Thermo Fisher Scientific Inc., Vitrolife AB, Irvine Scientific, EMD Sereno Inc., Genea Ltd., Rocket Medical PLC, Fertility Focus Ltd., Boston IVF, and Progyny Inc.
The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the in-vitro fertilization market.
This report also provides the competitive landscape of the leading players in Global In-vitro Fertilization market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.
Market Report Scope:
Healthcare Category: BIOTECHNOLOGY / HEALTH & HYGIENE
- Fresh Donor
- Frozen Donor
- Fresh Non-donor
- Frozen Non-donor
- Intracytoplasmic Sperm Injection (ICSI)
- Frozen Embryo Replacement (FER)
- Pre-Implantation Genetic Diagnosis (PGD)
- North America
- Asia Pacific
- Rest of the World
Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities